[希加曲班的临床经验] - Suppr

Suppr

超能文献

[Clinical experience with xigris].

作者信息

Wyncoll D

机构信息

Guy's et St Thomas' Hospital, Lambeth Palace Road, Londres SE1 7EH, Royaume-Uni.

出版信息

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:46-7.

PMID:15359944

Abstract

摘要

相似文献

[Clinical experience with xigris].

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:46-7.

Xigris: reducing mortality in adult patients with severe sepsis.

Urol Nurs. 2002 Jun;22(3):200-1.

[Xigris and corticoids: what are the perspectives for the patient with severe sepsis?].

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:43-5.

Activated protein C (Xigris): a drug in trouble.

Acta Anaesthesiol Scand. 2007 Feb;51(2):261-2. doi: 10.1111/j.1399-6576.2006.01215.x.

The Sepsis Saga: Consensus to Xigris.

Air Med J. 2016 Jul-Aug;35(4):194-6. doi: 10.1016/j.amj.2016.04.010. Epub 2016 Jun 3.

[Surgical patients with severe sepsis: first results of the PROWESS study. Demographic data].

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:38-9.

[Xigris--activated protein C].

Ugeskr Laeger. 2004 Mar 8;166(11):1002-4.

Should we be using activated protein C to treat severe sepsis?

Br J Hosp Med (Lond). 2009 Aug;70(8):484. doi: 10.12968/hmed.2009.70.8.43548.

Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than death.

Crit Care Med. 2003 Mar;31(3):984-5. doi: 10.1097/01.CCM.0000055386.01914.0C.

[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].

Ugeskr Laeger. 2004 Mar 8;166(11):997-1002.

引用本文的文献

Practical aspects of treatment with drotrecogin alfa (activated).

Crit Care. 2007;11 Suppl 5(Suppl 5):S7. doi: 10.1186/cc6158.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Clinical experience with xigris].

作者信息

Wyncoll D

机构信息

Guy's et St Thomas' Hospital, Lambeth Palace Road, Londres SE1 7EH, Royaume-Uni.

出版信息

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:46-7.

PMID:15359944

Abstract

摘要

相似文献

[Clinical experience with xigris].

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:46-7.

Xigris: reducing mortality in adult patients with severe sepsis.

Urol Nurs. 2002 Jun;22(3):200-1.

[Xigris and corticoids: what are the perspectives for the patient with severe sepsis?].

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:43-5.

Activated protein C (Xigris): a drug in trouble.

Acta Anaesthesiol Scand. 2007 Feb;51(2):261-2. doi: 10.1111/j.1399-6576.2006.01215.x.

The Sepsis Saga: Consensus to Xigris.

Air Med J. 2016 Jul-Aug;35(4):194-6. doi: 10.1016/j.amj.2016.04.010. Epub 2016 Jun 3.

[Surgical patients with severe sepsis: first results of the PROWESS study. Demographic data].

Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:38-9.

[Xigris--activated protein C].

Ugeskr Laeger. 2004 Mar 8;166(11):1002-4.

Should we be using activated protein C to treat severe sepsis?

Br J Hosp Med (Lond). 2009 Aug;70(8):484. doi: 10.12968/hmed.2009.70.8.43548.

Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than death.

Crit Care Med. 2003 Mar;31(3):984-5. doi: 10.1097/01.CCM.0000055386.01914.0C.

[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].

Ugeskr Laeger. 2004 Mar 8;166(11):997-1002.

引用本文的文献

Practical aspects of treatment with drotrecogin alfa (activated).

Crit Care. 2007;11 Suppl 5(Suppl 5):S7. doi: 10.1186/cc6158.